Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisoprolol ODF in Essential Hypertension (BETTER)
NCT05880056Phase 4Recruiting
- Sponsor
- Genuine Research Center
- Start
- Aug 2024
- Primary completion
- Apr 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bisoprolol in essential hypertension, sponsored by Genuine Research Center. Primary endpoint: Frequency of first dose hypotension. Started Aug 2024; status: recruiting.
02
Drugs
bisoprolol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT05880056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05880056.